Dr. Bessy Flores Chang, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,485 | 108 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,491 | 25 | $0 (2023) |
| Novo Nordisk Inc | $906.94 | 29 | $0 (2024) |
| Amgen Inc. | $688.56 | 15 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $468.68 | 13 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $282.16 | 7 | $0 (2023) |
| GENZYME CORPORATION | $120.69 | 1 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $105.16 | 5 | $0 (2024) |
| Medtronic, Inc. | $103.05 | 1 | $0 (2022) |
| Dynavax Technologies Corporation | $73.07 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $65.49 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $621.62 | 22 | Amgen Inc. ($270.00) |
| 2023 | $734.38 | 22 | AstraZeneca Pharmaceuticals LP ($166.82) |
| 2022 | $1,463 | 33 | AstraZeneca Pharmaceuticals LP ($473.34) |
| 2021 | $1,502 | 28 | AstraZeneca Pharmaceuticals LP ($687.28) |
| 2020 | $163.63 | 3 | AstraZeneca Pharmaceuticals LP ($163.63) |
All Payment Transactions
108 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Cardiology | ||||||
| 11/01/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $32.59 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Obesity | ||||||
| 10/15/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $30.31 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/24/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $33.81 | General |
| Category: Hepatitis B Vaccine | ||||||
| 08/27/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Inflammation | ||||||
| 08/23/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Rare Disease | ||||||
| 08/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $34.10 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $32.94 | General |
| Category: Cardio-renal | ||||||
| 06/28/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Nephrology | ||||||
| 06/06/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $124.12 | General |
| Category: Inflammation | ||||||
| 05/09/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $7.55 | General |
| Category: Inflammation | ||||||
| 04/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: Cardio-renal | ||||||
| 04/10/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Diabetes | ||||||
| 03/29/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $31.31 | General |
| 03/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Diabetes | ||||||
| 03/15/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Inflammation | ||||||
| 03/11/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Hepatitis B Vaccine | ||||||
| 03/11/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Hepatitis B Vaccine | ||||||
| 03/08/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: NEPHROLOGY | ||||||
| 02/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Cardio-renal | ||||||
| 02/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Diabetes | ||||||
| 12/15/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2023 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $124.12 | General |
| Category: Bone Health | ||||||
| 11/10/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 96 | 235 | $69,709 | $18,562 |
| 2022 | 9 | 196 | 459 | $174,432 | $51,942 |
| 2021 | 9 | 194 | 548 | $231,124 | $72,261 |
| 2020 | 4 | 70 | 165 | $84,099 | $26,683 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 132 | $33,178 | $9,537 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 22 | 42 | $15,952 | $3,554 | 22.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 25 | 28 | $13,790 | $3,335 | 24.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 14 | 33 | $6,788 | $2,136 | 31.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Facility | 2022 | 11 | 68 | $59,500 | $18,432 | 31.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 54 | 207 | $43,564 | $13,691 | 31.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 21 | 25 | $14,762 | $4,622 | 31.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 23 | 46 | $17,618 | $4,106 | 23.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 21 | 43 | $9,116 | $2,818 | 30.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 22 | 22 | $10,685 | $2,796 | 26.2% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 16 | 20 | $7,455 | $2,347 | 31.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 13 | 13 | $6,617 | $1,682 | 25.4% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 15 | 15 | $5,115 | $1,447 | 28.3% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Facility | 2021 | 15 | 92 | $80,500 | $25,755 | 32.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 63 | 271 | $57,013 | $18,247 | 32.0% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Facility | 2021 | 15 | 40 | $24,000 | $7,684 | 32.0% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Facility | 2021 | 12 | 17 | $17,986 | $5,756 | 32.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 19 | 20 | $11,560 | $3,769 | 32.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 34 | $10,256 | $3,296 | 32.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 21 | 33 | $12,870 | $3,028 | 23.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 17 | 23 | $11,017 | $2,965 | 26.9% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 18 | 18 | $5,922 | $1,760 | 29.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Facility | 2020 | 17 | 48 | $40,224 | $12,726 | 31.6% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Facility | 2020 | 20 | 36 | $25,416 | $8,130 | 32.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 22 | 70 | $14,840 | $4,747 | 32.0% |
About Dr. Bessy Flores Chang, MD
Dr. Bessy Flores Chang, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2014. The National Provider Identifier (NPI) number assigned to this provider is 1437563137.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bessy Flores Chang, MD has received a total of $4,485 in payments from pharmaceutical and medical device companies, with $621.62 received in 2024. These payments were reported across 108 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($4,485).
As a Medicare-enrolled provider, Flores Chang has provided services to 556 Medicare beneficiaries, totaling 1,407 services with total Medicare billing of $169,447. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Nephrology
- Location Bronx, NY
- Active Since 06/20/2014
- Last Updated 07/22/2020
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437563137
Products in Payments
- LOKELMA (Drug) $880.15
- Ozempic (Drug) $703.20
- Kerendia (Drug) $468.68
- FARXIGA (Drug) $398.78
- EVENITY (Biological) $314.80
- LUPKYNIS (Drug) $282.16
- TAVNEOS (Drug) $173.00
- JEVTANA (Drug) $120.69
- JYNARQUE (Drug) $105.16
- Aranesp (Biological) $103.76
- ELLIPSYS VASCULAR ACCESS SYSTEM (Device) $103.05
- KRYSTEXXA (Biological) $97.00
- Rybelsus (Drug) $89.16
- Heplisav-B (Drug) $73.07
- RYBELSUS (Drug) $69.35
- ELIQUIS (Drug) $65.49
- Velphoro (Drug) $47.47
- Veltassa (Drug) $37.84
- FUROSCIX (Drug) $23.98
- Wegovy (Drug) $23.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Bronx
Dr. David Altschul, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $394,687
Edvard Skripochnik, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $127,559
Dr. Cynthia Armand
Student in an Organized Health Care Education/Training Program — Payments: $68,024
Dr. Eric Woods, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $40,336
Ms. Kavita Gupta, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $31,772
Dr. Dmitriy Nevelev, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $30,107